{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:15:35Z","timestamp":1783196135331,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP200383"],"award-info":[{"award-number":["RP200383"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clbc.2026.04.018","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:16:25Z","timestamp":1780521385000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Cancer Histories Among Breast Cancer Patients With Li-Fraumeni Syndrome From a Single Institution"],"prefix":"10.1016","volume":"26","author":[{"given":"Ashley H.","family":"Woodson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydah","family":"Al-Awadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Corredor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacynda","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiam M.","family":"Abdel-Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica M.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawen","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Roland L.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney D.","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu K.","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.04.018_bib0001","series-title":"GeneReviews Seattle (WA)","article-title":"Li-Fraumeni Syndrome","author":"Schneider","year":"1993"},{"issue":"5","key":"10.1016\/j.clbc.2026.04.018_bib0002","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"4","key":"10.1016\/j.clbc.2026.04.018_bib0003","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.clbc.2026.04.018_bib0004","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.clbc.2026.04.018_bib0005","first-page":"6643","article-title":"Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype","volume":"63","author":"Olivier","year":"2003","journal-title":"Cancer Res"},{"issue":"23","key":"10.1016\/j.clbc.2026.04.018_bib0006","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clbc.2026.04.018_bib0007","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jnci\/djae074","article-title":"TP53-associated early breast cancer: new observations from a large cohort","volume":"116","author":"Sandoval","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.clbc.2026.04.018_bib0008","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","article-title":"Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort","volume":"133","author":"Masciari","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clbc.2026.04.018_bib0009","first-page":"1298","article-title":"Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families","volume":"54","author":"Birch","year":"1994","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.clbc.2026.04.018_bib0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamasurg.2018.0035","article-title":"Race\/Ethnicity and Age Distribution of Breast Cancer Diagnosis in the United States","volume":"153","author":"Stapleton","year":"2018","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.clbc.2026.04.018_bib0011","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.04.018_bib0012","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/cncr.26377","article-title":"Early onset HER2-positive breast cancer is associated with germline TP53 mutations","volume":"118","author":"Melhem-Bertrandt","year":"2012","journal-title":"Cancer"},{"issue":"4785","key":"10.1016\/j.clbc.2026.04.018_bib0013","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.clbc.2026.04.018_bib0014","first-page":"4960","article-title":"Her-2\/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease","volume":"53","author":"Press","year":"1993","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.clbc.2026.04.018_bib0015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.clbc.2026.04.018_bib0016","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"de Andrade","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.04.018_bib0017","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41379-020-0610-4","article-title":"Histopathologic features of breast cancer in Li-Fraumeni syndrome","volume":"34","author":"Kuba","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.clbc.2026.04.018_bib0018","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-018-4613-1","article-title":"Mutant p53 gain of function induces HER2 over-expression in cancer cells","volume":"18","author":"Rom\u00e1n-Rosales","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2026.04.018_bib0019","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.ede.0000072105.39021.6d","article-title":"The descriptive epidemiology of second primary breast cancer","volume":"14","author":"Bernstein","year":"2003","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.clbc.2026.04.018_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.clbc.2026.04.018_bib0021","first-page":"101","article-title":"Germline mutations in the TP53 gene","volume":"25","author":"Eeles","year":"1995","journal-title":"Cancer Surv"},{"issue":"6","key":"10.1016\/j.clbc.2026.04.018_bib0022","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1055-9965.EPI-16-0695","article-title":"Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO","volume":"26","author":"Peng","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.clbc.2026.04.018_bib0023","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2026.04.018_bib0024","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","article-title":"Consensus Guidelines on Genetic; Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons","volume":"26","author":"Manahan","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.04.018_bib0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1158\/0008-5472.CAN-19-0725","article-title":"Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective","volume":"80","author":"Shin","year":"2020","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.clbc.2026.04.018_bib0026","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.04.018_bib0027","article-title":"LFSPROShiny: An Interactive R\/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations","volume":"8","author":"Nguyen","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"issue":"18","key":"10.1016\/j.clbc.2026.04.018_bib0028","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1200\/JCO.23.01926","article-title":"Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data","volume":"42","author":"Nguyen","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.04.018_bib0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13053-022-00213-5","article-title":"Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system","volume":"20","author":"Muessig","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"issue":"1","key":"10.1016\/j.clbc.2026.04.018_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10689-019-00153-5","article-title":"Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome)","volume":"19","author":"Petry","year":"2020","journal-title":"Fam Cancer"},{"key":"10.1016\/j.clbc.2026.04.018_bib0031","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-5-104","article-title":"Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome","volume":"5","author":"Heymann","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2026.04.018_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.112952","article-title":"Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy","volume":"191","author":"Lee","year":"2023","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2026.04.018_bib0033","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:25:03Z","timestamp":1783193103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1526820926000728"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.04.018","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics and Cancer Histories Among Breast Cancer Patients With Li-Fraumeni Syndrome From a Single Institution","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}